Hepatocyte Growth Factor Activator Inhibitor-1 Has a Complex Subcellular Itinerary

Overview

Journal Biochem J

Specialty Biochemistry

Date 2008 Apr 12

PMID 18402552

Citations 17

Authors

Sine Godiksen

Joanna Selzer-Plon

Esben D K Pedersen

Kathrine Abell

Hanne B Rasmussen

Roman Szabo

Thomas H Bugge

Lotte K Vogel

Affiliations

Soon will be listed here.

Abstract

HAI-1 [HGF (hepatocyte growth factor) activator inhibitor-1] is a Kunitz-type transmembrane serine protease inhibitor that forms inhibitor complexes with the trypsin-like serine protease, matriptase. HAI-1 is essential for mouse placental development and embryo survival and together with matriptase it is a key regulator of carcinogenesis. HAI-1 is expressed in polarized epithelial cells, which have the plasma membrane divided by tight junctions into an apical and a basolateral domain. In the present study we show that HAI-1 at steady-state is mainly located on the basolateral membrane of both Madin-Darby canine kidney cells and mammary gland epithelial cells. After biosynthesis, HAI-1 is exocytosed mainly to the basolateral plasma membrane from where 15% of the HAI-1 molecules are proteolytically cleaved and released into the basolateral medium. The remaining membrane-associated HAI-1 is endocytosed and then recycles between the basolateral plasma membrane and endosomes for hours until it is transcytosed to the apical plasma membrane. Minor amounts of HAI-1 present at the apical plasma membrane are proteolytically cleaved and released into the apical medium. Full-length membrane-bound HAI-1 has a half-life of 1.5 h and is eventually degraded in the lysosomes, whereas proteolytically released HAI-1 is more stable. HAI-1 is co-localized with its cognate protease, matriptase, at the basolateral plasma membrane. We suggest that HAI-1, in addition to its protease inhibitory function, plays a role in transporting matriptase as a matriptase-HAI-1 complex from the basolateral plama membrane to the apical plasma membrane, as matriptase is known to interact with prostasin, located at the apical plasma membrane.

Citing Articles

The intracellular seven amino acid motif EEGEVFL is required for matriptase vesicle sorting and translocation to the basolateral plasma membrane.

Tseng C, Jia B, Barndt R, Dai Y, Chen Y, Du P PLoS One. 2020; 15(2):e0228874.

PMID: 32049977 PMC: 7015431. DOI: 10.1371/journal.pone.0228874.

Hemagglutinin Cleavability, Acid Stability, and Temperature Dependence Optimize Influenza B Virus for Replication in Human Airways.

Laporte M, Stevaert A, Raeymaekers V, Boogaerts T, Nehlmeier I, Chiu W J Virol. 2019; 94(1).

PMID: 31597759 PMC: 6912116. DOI: 10.1128/JVI.01430-19.

Expression of serine peptidase inhibitor Kunitz type 1 in differentiated thyroid cancer.

Liu C, Yang P, Chien M, Chang Y, Lin C, Cheng S Histochem Cell Biol. 2018; 149(6):635-644.

PMID: 29532159 DOI: 10.1007/s00418-018-1660-2.

Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion.

Tervonen T, Belitskin D, Pant S, Englund J, Marques E, Ala-Hongisto H Oncogene. 2015; 35(14):1832-46.

PMID: 26165838 DOI: 10.1038/onc.2015.248.

Detection of active matriptase using a biotinylated chloromethyl ketone peptide.

Godiksen S, Soendergaard C, Friis S, Jensen J, Bornholdt J, Sales K PLoS One. 2013; 8(10):e77146.

PMID: 24204759 PMC: 3799725. DOI: 10.1371/journal.pone.0077146.

References

Takeuchi T, Harris J, Huang W, Yan K, Coughlin S, Craik C . Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem. 2000; 275(34):26333-42. DOI: 10.1074/jbc.M002941200. View

Verghese G, Gutknecht M, Caughey G . Prostasin regulates epithelial monolayer function: cell-specific Gpld1-mediated secretion and functional role for GPI anchor. Am J Physiol Cell Physiol. 2006; 291(6):C1258-70. PMC: 2271112. DOI: 10.1152/ajpcell.00637.2005. View

Szabo R, Molinolo A, List K, Bugge T . Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development. Oncogene. 2006; 26(11):1546-56. DOI: 10.1038/sj.onc.1209966. View

Tsuzuki S, Murai N, Miyake Y, Inouye K, Hirayasu H, Iwanaga T . Evidence for the occurrence of membrane-type serine protease 1/matriptase on the basolateral sides of enterocytes. Biochem J. 2005; 388(Pt 2):679-87. PMC: 1138976. DOI: 10.1042/BJ20041639. View

Herter S, Piper D, Aaron W, Gabriele T, Cutler G, Cao P . Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem J. 2005; 390(Pt 1):125-36. PMC: 1184568. DOI: 10.1042/BJ20041955. View

Lin C, Anders J, Johnson M, Dickson R . Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem. 1999; 274(26):18237-42. DOI: 10.1074/jbc.274.26.18237. View

Kato K, Jeanneau C, Tarp M, Benet-Pages A, Lorenz-Depiereux B, Bennett E . Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J Biol Chem. 2006; 281(27):18370-7. DOI: 10.1074/jbc.M602469200. View

Kilpatrick L, Harris R, Owen K, Bass R, Ghorayeb C, Bar-Or A . Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase. Blood. 2006; 108(8):2616-23. DOI: 10.1182/blood-2006-02-001073. View

Oberst M, Anders J, Xie B, Singh B, OSSANDON M, Johnson M . Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am J Pathol. 2001; 158(4):1301-11. PMC: 1891898. DOI: 10.1016/S0002-9440(10)64081-3. View

10.

Mostov K, Su T, Ter Beest M . Polarized epithelial membrane traffic: conservation and plasticity. Nat Cell Biol. 2003; 5(4):287-93. DOI: 10.1038/ncb0403-287. View

11.

Kataoka H, Suganuma T, Shimomura T, Itoh H, Kitamura N, Nabeshima K . Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues. J Histochem Cytochem. 1999; 47(5):673-82. DOI: 10.1177/002215549904700509. View

12.

Parry S, Hanisch F, Leir S, Sutton-Smith M, Morris H, Dell A . N-Glycosylation of the MUC1 mucin in epithelial cells and secretions. Glycobiology. 2006; 16(7):623-34. DOI: 10.1093/glycob/cwj110. View

13.

Lee M, Tseng I, Wang Y, Kiyomiya K, Johnson M, Dickson R . Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain. Am J Physiol Cell Physiol. 2007; 293(1):C95-105. DOI: 10.1152/ajpcell.00611.2006. View

14.

Pagano A, Crottet P, Prescianotto-Baschong C, Spiess M . In vitro formation of recycling vesicles from endosomes requires adaptor protein-1/clathrin and is regulated by rab4 and the connector rabaptin-5. Mol Biol Cell. 2004; 15(11):4990-5000. PMC: 524758. DOI: 10.1091/mbc.e04-04-0355. View

15.

Oberst M, Johnson M, Dickson R, Lin C, Singh B, Stewart M . Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. Clin Cancer Res. 2002; 8(4):1101-7. View

16.

List K, Szabo R, Molinolo A, Nielsen B, Bugge T . Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis. Am J Pathol. 2006; 168(5):1513-25. PMC: 1606590. DOI: 10.2353/ajpath.2006.051071. View

17.

Lee S, Dickson R, Lin C . Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem. 2000; 275(47):36720-5. DOI: 10.1074/jbc.M007802200. View

18.

Lerdrup M, Hommelgaard A, Grandal M, van Deurs B . Geldanamycin stimulates internalization of ErbB2 in a proteasome-dependent way. J Cell Sci. 2005; 119(Pt 1):85-95. DOI: 10.1242/jcs.02707. View

19.

Shimomura T, Denda K, Kawaguchi T, Matsumoto K, Miyazawa K, Kitamura N . Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form. J Biochem. 1999; 126(5):821-8. DOI: 10.1093/oxfordjournals.jbchem.a022522. View

20.

Denda K, Shimomura T, Kawaguchi T, Miyazawa K, Kitamura N . Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1. J Biol Chem. 2002; 277(16):14053-9. DOI: 10.1074/jbc.M112263200. View